Autumn Glory Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.91M Buy
+2,428
New +$2.48M 0.83% 31
2026
Q1
Sell
-1,367
Closed -$1.47M 218
2025
Q4
$1.47M Sell
1,367
-311
-19% -$297K 0.51% 54
2025
Q3
$1.28M Buy
1,678
+634
+61% +$472K 0.53% 53
2025
Q2
$814K Buy
1,044
+341
+49% +$265K 0.38% 71
2025
Q1
$2.58M Buy
703
+12
+2% +$9.98K 1.28% 19
2024
Q4
$533K Buy
+691
New +$572K 0.26% 94

Other funds holding LLY

Autumn Glory Partners's LLY Position: Q2 2026 in Review

Autumn Glory Partners opened a new position in Eli Lilly (LLY) in Q2 2026: 2,428 shares worth $2.91M. The stake represents 0.83% of the portfolio and ranks #31 among its holdings. This is a return to the name: Autumn Glory Partners previously reported a position in LLY as recently as Q4 2025.

Autumn Glory Partners first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Autumn Glory Partners held 2,428 shares of Eli Lilly worth $2.91M as of Q2 2026.
  • Eli Lilly was a new Autumn Glory Partners position in Q2 2026.
  • Eli Lilly made up 0.83% of Autumn Glory Partners's portfolio in Q2 2026, its #31 holding.
  • Autumn Glory Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Autumn Glory Partners's 13F filing for Q2 2026, filed 3 Aug 2026.